Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Aakash Putta"'
Autor:
V V Pavan Kedar Mukthinuthalapati, Sean Smith, Sunny R K Singh, Muhammad Zain Farooq, Aakash Putta, Shweta Gupta
Publikováno v:
Clinical lung cancer. 21(5)
Lung cancer screening (LCS) with annual low-dose computed tomography in high-risk groups decreases the mortality related to lung cancer. Its implementation rate has been low, and knowledge relating to LCS has not been assessed in providers treating u
Publikováno v:
International Journal of Reproduction, Contraception, Obstetrics and Gynecology. :1124-1129
Background: Pregnancy related low lumbo- pelvic pain (PLPP) is a common complaint that occurs in 60-70% of pregnancies. It can begin at any point during pregnancy. Although most cases are mild, approximately one third of women experience severe pain.
Autor:
V V Pavan Kedar Mukthinuthalapati, Muhammad Zain Farooq, Ankit Mangla, Muhammad Saad Farooq, Sheeba Ba Aqeel, Prasanth Lingamaneni, Paul G. Rubinstein, Aakash Putta
Publikováno v:
Blood. 134:4963-4963
Introduction: Current expert recommendations recommend double therapy (DT) over triple therapy (TT) in atrial fibrillation patients post percutaneous coronary intervention (PCI) to prevent the incidence of stroke. Though previous studies have focused
Autor:
Aakash Putta, Muhammad Zain Farooq, Shristi Upadhyay Banskota, Sindhu Janarthanam Malapati, Kumar Kunnal Batra, Hafeez Shaka, Sunny R K Singh
Publikováno v:
Blood. 134:3691-3691
Introduction: There are multiple mechanisms of occurrence of TMA. Some of the etiologies are associated with high morbidity and mortality, but there are very subtle differences in presentation. A high index of suspicion is recommended for thrombotic
Autor:
Aakash Putta, Sagar Ranka, Juan Del Cid Fratti, Alok Uprety, Jishanth Mattumpuram, Hashim Mann, Setri Fugar, Tauseef Akhtar, Yasmeen Golzar
Publikováno v:
Journal of the American College of Cardiology. 73:471
Autor:
Koosha Paydary, Jiaxiang Liu, Jayasree Krishnan, Barbra Yim, Alok Uprety, Jishanth Mattumpuram, Aakash Putta, Ankit Mangla, Tauseef Akhtar, Muhammad Umair Mushtaq, Yanting Wang, Thomas E. Lad, Hashim Mann
Publikováno v:
Blood. 132:5064-5064
Introduction: Rivaroxaban is a target specific oral anticoagulant approved for treatment of deep venous thromboembolism (DVT), pulmonary embolism (PE) and risk reduction in patients with DVT/PE requiring continued anticoagulation. The XALIA study sho
Publikováno v:
Journal of Clinical Oncology. 36:e21104-e21104
e21104Background: Clinical stage at diagnosis determines prognosis in lung cancer. One third of patients are metastatic at diagnosis with median survival of 1 year. Lately, survival has improved wi...
Publikováno v:
Journal of Clinical Oncology. 36:e15004-e15004
e15004Background: Immune Checkpoint Inhibitors (ICIs) have shown remarkable efficacy, durable responses and prolonged overall survival compared to chemotherapy in many solid tumors. However, most s...